Page last updated: 2024-11-02

pentoxifylline and Endolymphatic Hydrops

pentoxifylline has been researched along with Endolymphatic Hydrops in 1 studies

Endolymphatic Hydrops: An accumulation of ENDOLYMPH in the inner ear (LABYRINTH) leading to buildup of pressure and distortion of intralabyrinthine structures, such as COCHLEA and SEMICIRCULAR CANALS. It is characterized by SENSORINEURAL HEARING LOSS; TINNITUS; and sometimes VERTIGO.

Research Excerpts

ExcerptRelevanceReference
"Low-frequency hearing impairment (LFHI) is mainly attributed to endolymphatic hydrops and has a great variety of possible outcomes."1.33Prognostic relevance of anamnestic and diagnostic parameters in low-frequency hearing impairment. ( Maier, W; Schipper, J, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Maier, W1
Schipper, J1

Other Studies

1 other study available for pentoxifylline and Endolymphatic Hydrops

ArticleYear
Prognostic relevance of anamnestic and diagnostic parameters in low-frequency hearing impairment.
    The Journal of laryngology and otology, 2006, Volume: 120, Issue:8

    Topics: Acetazolamide; Age Factors; Aged; Audiometry, Pure-Tone; Auditory Threshold; Diuretics; Electronysta

2006